Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aktis Oncology, Inc. | 3,285,661 | reported | 12 Jan 2026 | tx 7+4,235,403−15,227,273 |
| iTeos Therapeutics, Inc. | 3,208,860 | reported | 11 Oct 2021 | tx 7−143,247 |
| RHYTHM PHARMACEUTICALS, INC. | 909,258 | reported | 15 Mar 2021 | tx 56+6,104,930−25,705,169 |
| MPM ACQUISITION CORP | 71,638 | reported | 23 Apr 2013 | tx 3+281,001 |
| Conatus Pharmaceuticals Inc | 32,220 | reported | 30 Jul 2013 | tx 6+1,224,300−8,599,171 |
| Repare Therapeutics Inc. | 27,200 | reported | 08 Jun 2023 | tx 60+3,100,972−3,514,908 |
| COMBINATORX, INC | 15,000 | reported | 23 May 2012 | tx 4+60,000 |
| Entrada Therapeutics, Inc. | 11,918 | reported | 02 Jun 2022 | tx 7+4,461,254−31,300,916 |
| Celladon Corp | 0 | reported | 04 Feb 2014 | tx 7+1,084,292−12,018,223 |
| ARATANA THERAPEUTICS, INC. | 0 | reported | 07 Mar 2014 | tx 8+127,302−1,012,539 |
5 purchases reported after at least 12 months of silence — most recent on 12 Jan 2026.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jan 2026 | CONVERSION | Aktis Oncology, Inc. | 2,688,270 | — | |
| 12 Jan 2026 | PURCHASE | Aktis Oncology, Inc. | 232,870 | 18.00 USD | first after silence |
| 12 Jan 2026 | CONVERSION | Aktis Oncology, Inc. | 597,391 | — | |
| 12 Jan 2026 | CONVERSION | Aktis Oncology, Inc. | 716,872 | — | |
| 12 Jan 2026 | CONVERSION | Aktis Oncology, Inc. | 2,272,727 | 0.00 USD | deriv |
| 12 Jan 2026 | CONVERSION | Aktis Oncology, Inc. | 2,727,273 | 0.00 USD | deriv |
| 12 Jan 2026 | CONVERSION | Aktis Oncology, Inc. | 10,227,273 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Repare Therapeutics Inc. | 27,200 | 0.00 USD | deriv |
| 02 Jun 2022 | GRANT_AWARD | Entrada Therapeutics, Inc. | 11,918 | 0.00 USD | deriv |
| 13 May 2022 | GRANT_AWARD | Repare Therapeutics Inc. | 49,000 | 0.00 USD | deriv |
| 02 Nov 2021 | CONVERSION | Entrada Therapeutics, Inc. | 509,024 | — | |
| 02 Nov 2021 | PURCHASE | Entrada Therapeutics, Inc. | 100,000 | 20.00 USD | first after silence |
| 02 Nov 2021 | CONVERSION | Entrada Therapeutics, Inc. | 3,816,760 | — | |
| 02 Nov 2021 | CONVERSION | Entrada Therapeutics, Inc. | 27,617,675 | 0.00 USD | deriv |
| 02 Nov 2021 | CONVERSION | Entrada Therapeutics, Inc. | 3,683,241 | 0.00 USD | deriv |
| 28 Oct 2021 | GRANT_AWARD | Entrada Therapeutics, Inc. | 23,552 | 0.00 USD | deriv |
| 08 Oct 2021 | SALE | iTeos Therapeutics, Inc. | 2,032 | 27.01 USD | |
| 07 Oct 2021 | SALE | iTeos Therapeutics, Inc. | 1,149 | 27.00 USD | |
| 11 Oct 2021 | SALE | iTeos Therapeutics, Inc. | 48,812 | 27.24 USD | |
| 17 Sept 2021 | SALE | iTeos Therapeutics, Inc. | 45,698 | 28.82 USD | |
| 16 Sept 2021 | SALE | iTeos Therapeutics, Inc. | 21,253 | 28.47 USD | |
| 20 Sept 2021 | SALE | iTeos Therapeutics, Inc. | 10,602 | 27.03 USD | |
| 20 Sept 2021 | SALE | iTeos Therapeutics, Inc. | 13,701 | 27.84 USD | |
| 05 Aug 2021 | OTHER | CHIASMA, INC | 13,000 | 0.00 USD | deriv |
| 05 Aug 2021 | OTHER | CHIASMA, INC | 13,000 | 0.00 USD | deriv |